Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

WORK Medical Technology (WOK) Assets (2023 - 2025)

Historic Assets for WORK Medical Technology (WOK) over the last 3 years, with Q3 2025 value amounting to $33.2 million.

  • WORK Medical Technology's Assets fell 853.59% to $33.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $33.2 million, marking a year-over-year decrease of 853.59%. This contributed to the annual value of $33.2 million for FY2025, which is 853.59% down from last year.
  • WORK Medical Technology's Assets amounted to $33.2 million in Q3 2025, which was down 853.59% from $34.7 million recorded in Q1 2025.
  • WORK Medical Technology's Assets' 5-year high stood at $36.3 million during Q3 2024, with a 5-year trough of $30.0 million in Q3 2023.
  • For the 3-year period, WORK Medical Technology's Assets averaged around $33.5 million, with its median value being $33.9 million (2025).
  • Its Assets has fluctuated over the past 5 years, first surged by 2100.1% in 2024, then tumbled by 853.59% in 2025.
  • WORK Medical Technology's Assets (Quarter) stood at $30.0 million in 2023, then rose by 21.0% to $36.3 million in 2024, then decreased by 8.54% to $33.2 million in 2025.
  • Its last three reported values are $33.2 million in Q3 2025, $34.7 million for Q1 2025, and $36.3 million during Q3 2024.